Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. by Blencowe, Hannah et al.
Blencowe, H; Vos, T; Lee, AC; Philips, R; Lozano, R; Alvarado, MR;
Cousens, S; Lawn, JE (2013) Estimates of neonatal morbidities and
disabilities at regional and global levels for 2010: introduction, meth-
ods overview, and relevant findings from the Global Burden of Dis-
ease study. Pediatric research, 74 Suppl 1. pp. 4-16. ISSN 0031-3998
DOI: 10.1038/pr.2013.203
Downloaded from: http://researchonline.lshtm.ac.uk/1440265/
DOI: 10.1038/pr.2013.203
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-sa/2.5/
Articles Population Study nature publishing group
Background: Neonatal mortality and morbidity are 
increasingly recognized as important globally, but detailed 
estimates of neonatal morbidity from conditions and long-
term consequences are yet to be published.
Methods: We describe the general methods for systematic 
reviews, meta-analyses, and modeling used in this supplement, 
highlighting differences from the Global Burden of Disease 
(GBD2 010) inputs and methods. For five conditions (preterm 
birth, retinopathy of prematurity, intrapartum-related condi-
tions, neonatal infections, and neonatal jaundice), a standard 
three-step compartmental model was applied to estimate—
by region, for 2010—the numbers of (i) affected births by sex, 
(ii) postneonatal survivors, and (iii) impaired postneonatal sur-
vivors. For conditions included in GBD2010 analyses (preterm 
birth and intrapartum-related conditions), impairment at all 
ages was estimated, and disability weights were applied to esti-
mate years lived with disability (YLD) and summed with years 
of life lost (YLL) to calculate disability-adjusted life years (DALYs).
results: GBD2010 estimated neonatal conditions (preterm 
birth, intrapartum-related, neonatal sepsis, and “other neona-
tal”) to be responsible for 202 million DALYs or 8.1% (7.3–9.0%) 
of the worldwide total. Mortality contributed 95% of the DALYs, 
and the estimated 26% reduction in neonatal condition DALYs 
since 1990 is primarily due to a 44% reduction in neonatal 
mortality rate due to these conditions, counterbalanced by 
increased numbers of babies born (17%). Impairment follow-
ing neonatal conditions remained stable globally and is there-
fore relatively more important, especially in high- and middle-
income countries. Crucial data gaps were identified.
conclusion: These results confirm neonatal conditions as a 
significant burden, reemphasizing the need to reduce deaths 
further, to count the linked 2.6 million stillbirths, and to better 
measure and address their long-term effects.
in 2011, around 135 million babies were born alive worldwide, and an estimated 3 million of these died during the first 28 d of 
life (1,2). During the past decade, some progress has been made 
in reducing neonatal mortality, but this progress has been slower 
than that for postneonatal (1–59 mo) and maternal mortality 
(2,3). Reducing neonatal deaths is increasingly being recognized 
as a public health priority largely because of the Millennium 
Development Goal 4—to reduce under-5 mortality by two-
thirds between 1990 and 2015 (Figure 1) (3). Neonatal deaths 
now account for more than 43% of child deaths below 5 y of age.
The slower progress in reducing newborn deaths brings these 
deaths to the top of the child mortality agenda moving into the 
post-Millennium Development Goal era (4,5). Widespread 
disparity in neonatal mortality exists both between and within 
individual countries, in many cases with substantial variation 
between regions and by socioeconomic class (6). Unlike many 
other child health issues, neonatal conditions, and particularly 
preterm birth, are associated with an important burden in high-
income countries (7). Advances in neonatal care since the 1970s 
have improved the survival of even the most vulnerable babies, 
for example, those born preterm before 28 completed weeks 
and those with severe congenital abnormalities. However, these 
survivors remain at risk of long-term sequelae (8).
Systematic national estimates of causes of neonatal mortality 
have been important in linking the large number of newborn 
deaths to programmatic solutions and action (3,9,10). However, 
neonatal morbidity and its long-term impact on health and 
impairment have received much less attention and are increas-
ingly important issues for individuals, families, and nations. To 
date, no systematic estimates of disability have been undertaken 
(1,10,11). As focus shifts to the post–Millennium Development 
Goal agenda, increasing recognition is being given to disability-
free survival, human capital, and sustainable development.
The Global Burden of Disease (GBD) and the use of disabil-
ity-adjusted life years (DALYs)—a composite measure of pre-
mature deaths (years of life lost (YLLs)) and poor health (years 
lived with disability (YLDs))—have revolutionized interna-
tional health metrics (Table 1). In the previous GBD exercises, 
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“perinatal conditions” and congenital abnormalities together 
contributed at least 10% of the total burden, more than three 
times the DALYs attributed to HIV/AIDS (12,13). However, 
limited description of the data inputs and estimation methods 
exists in the public domain. In December 2012, the latest GBD 
update (GBD2010) was published, presenting high-level meth-
ods and results for 291 conditions throughout the whole lifespan 
of a human, including DALYs at the global level (14–16).
The GBD expert team for neonatal conditions overlaps with 
the author group of this supplement. Here, we provide details 
for individual neonatal conditions in terms of data inputs, 
methods, and implications. In future, the GBD process aims 
to have continuous updates and in these articles, we outline 
where we have been able to increase or refine some of the data 
inputs since GBD2010 and to add some conditions that were 
not estimated in GBD2010, notably neonatal jaundice.
We have not included in this supplement the important 
burden of congenital abnormalities, which are estimated to 
contribute 2.6 million DALYs in 2010 (15). The inputs and 
methods for those will be summarized elsewhere. In addition, 
stillbirths are still uncounted in global burden estimates (17).
oBJectiVes and structure oF the suPPleMent
The supplement presents the most comprehensive set yet com-
piled of regional and global estimates of the incidence of the 
most common neonatal morbidities and the associated burden 
of impairment and disability.
In this first article, we describe the step-by-step approach that 
we used to estimate the burden of neonatal conditions in 2010. 
We also describe the methods used in GBD2010 to estimate 
trends over time and to generate YLDs and hence DALYs (used 
for preterm birth and intrapartum related conditions), in addi-
tion to presenting an overview of the relevant GBD2010 results. 
We then present a series of five articles quantifying the incidence/
prevalence and the long-term effects of some important causes of 
neonatal morbidity including preterm birth, retinopathy of pre-
maturity, intrapartum-related neonatal encephalopathy, severe 
neonatal infections, and severe hyperbilirubinemia. Each article 
describes the systematic searches performed, the data inputs and 
modeling methods used, and presents the model outputs. The 
limitations of the currently available data are examined, recom-
mendations are made for data improvement, and the program-
matic implications of the results are discussed (Table 2). The 
major programmatic implications for health programs and pro-
posed steps to improve measurement of the burden of neonatal 
morbidity to facilitate comparison within and between countries 
over time will be summarized elsewhere.
Methods
Literature Searches and Inputs for Estimation Parameters
Systematic literature reviews were undertaken covering the main online 
literature databases, including Pubmed/Medline, Embase, CAB abstracts, 
Popline, Web of Science, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Latin American and Caribbean Health Science 
(LILACS), and WHO Regional library databases (Eastern Mediterranean 
Regional Office (EMRO) Index Medicus, African Index Medicus, Pan 
American Health Organization (PAHO), Latin America and Caribbean 
Virtual Health Library, South East Asian Region (SEARO) Index 
Medicus, and Western Pacific Region (WPRO) Index Medicus). The aim 
of these searches was to identify data that could be used to estimate the 
parameters required as follows: (i) the incidence/prevalence of the neo-
natal condition of interest and any sex differences in incidence/preva-
lence. (ii) Case fatality risk for each condition during the neonatal period. 
(iii) Risk of impairment among babies surviving the neonatal period.
Details of search terms, condition-specific inclusion and exclusion 
criteria, and dates of last searches are provided in the condition-spe-
cific articles. Searches were last updated for each condition between 
December 2012 and January 2013, and hence, there are additional 
data included here that were not published at the time the expert 
group provided inputs to GBD2010 1 y previously.
Overview of Three-Step Compartmental Model to Estimate 
Neonatal Survivors With Impairment
A generic three-step compartmental model similar to that used in 
GBD2010 was applied to each condition (Figure 2). Specific differ-
ences between the inputs, methodology used, and results obtained 
here and those in GBD2010 are discussed in the relevant articles.
Step 1 involved estimation of the incidence/prevalence of the con-
dition and hence the number of affected babies;
Step 2 involved estimation of the neonatal case fatality risk of the 
condition and hence the number of postneonatal survivors;
Step 3 involved estimating the risk of impairment and hence the 
number of these survivors who were impaired.
Figure 1. Progress toward Millennium Development Goal 4 for child survival showing progress for 193 countries based on estimates by the United 
Nations (UN) and by the Institute for Health Metrics and Evaluation (IHME).
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The calculation of YLDs (Figure 2) was only undertaken for 
conditions in GBD2010 (preterm- and intrapartum-related 
conditions).
The steps above were applied in sequence for all live births in each 
country in 2010 using the number of live births by country from the UN 
population division (18). Unpublished data from UNPOP’s WPP2010 
series were used to estimate the number of live births by sex so that 
sex-specific estimates could be made. Country-level results were then 
summed to produce regional estimates. Results are presented by GBD 
superregional grouping, which condenses the 21 GBD regions into 7 
(Figure 3; see Supplementary Information online) (19).
Data abstracted from the literature searches were used as inputs 
to estimate the parameters required for each condition, undertaking 
meta-analyses where appropriate. Time trends from 1990 to 2010 
were calculated for conditions when sufficient data were available. 
However, owing to the lack of comparable time series data, robust 
trend estimates were not possible for many conditions.
We quantified the uncertainty surrounding these estimates by tak-
ing 1,000 random draws of the input parameters at each step, assum-
ing a normal distribution with mean equal to the point estimate of 
the parameter and SD equal to the estimated SE of the parameter. We 
summed the data at the worldwide or regional level for each draw and 
present the 2.5th and 97.5th percentiles of the resulting distributions 
as the uncertainty range.
We did not estimate YLDs using the compartmental model and 
hence did not estimate DALYs. All DALYs presented in this supple-
ment are those calculated for GBD2010, and we note where the data 
inputs differ from those used for GBD2010.
Pooling of Data by Country Context Groupings
Data were not available to estimate every parameter individually for 
each country, or for some conditions (or impairment outcomes), data 
were sparse even at the regional level. Hence, we sought to group 
countries that are similar in their access to and quality of care because 
these are closely linked to outcomes, including case fatality rate, risk 
of impairment, and excess postneonatal mortality risk. We also sought 
to apply a common approach across all the estimation exercises in this 
supplement. Recent work has highlighted the very different contexts, 
table 1. Terms and definitions used in burden of disease estimation
Neonatal mortality Deaths in the first 28 d of life, per 1,000 live births
YLL The number of years of life lost due to premature mortality, calculated as the number of deaths at each age multiplied by the 
standard life expectancy at that age (15).
YLD The number of years lived in less than full health. It is calculated as the prevalence of the sequelae multiplied by the GBD2010 
disability weight associated with the health state for that sequelae (15).
GBD2010 disability 
weight
These were derived based on surveys of different populations in five countries (household surveys in Bangladesh, Indonesia, 
Peru, and Tanzania and telephone interviews in the USA) and an open access Web-based survey (23). These surveys used 
paired comparison questions in which participants were asked to consider two hypothetical individuals with different health 
states and to state which person they considered healthier.
DALYs This is an absolute measure of health loss, which counts how many years of healthy life are lost due to death or nonfatal 
illness or impairment. It is calculated as the sum of YLLs and YLDs. GBD2010 differed from previous GBD studies in that no age 
weighting or discounting was used (less weight given to younger and older ages); prevalent YLDs rather than incident YLDs 
were calculated; and adjustment was made for comorbidity (19).
Neurodevelopmental 
and sensory impairment 
outcomes
A standard approach was used to assess neurodevelopmental and sensory impairment outcomes from the available study 
data. Neurodevelopmental impairment was classified as mild (mild cognitive and/or mild motor impairment) and moderate/
severe (either cognitive and/or motor impairment of at least moderate severity). Details of the impairment outcome 
definitions used across all articles in this supplement are provided in table 5.
GBD2010 This is the most recent edition of the Global Burden of Disease project coordinated by the IHME in Seattle but involving many 
experts around the world. For details, see http://www.healthmetricsandevaluation.org/.
Compartmental model This refers to a basic epidemiological model where the population is divided into compartments and with assumptions 
about the nature and time rate of transfer from one compartment to another. In this supplement, we use a three-step 
compartmental model as follows: Step 1: incidence or prevalence of the condition. Step 2: risk of death from the condition, 
leading to an estimate of survivors. Step 3: risk of impairment among survivors, leading to numbers of impaired or unimpaired 
survivors. Diseases that recur or may confer immunity have more complex compartmental linkages, but for neonatal 
conditions, these are usually a single episode, or of short duration, and the impairment effects are typically lifelong (Figure 2).
The definitions and ICD codes for each neonatal condition are specified in the condition-specific articles.
DALYs, disability-adjusted life years; GBD, Global Burden of Disease; ICD, International Classification of Diseases; YLD, years lived with disability; YLL, years of life lost.
table 2. Estimates of neonatal morbidities and long-term 
impairment included in the articles in this supplement 
Preterm birth (27)
 Prevalence of preterm birth by gestational age
 Gestational age–specific neonatal mortality
  Mild and moderate/severe long-term impairment following preterm 
birth by gestational age
Retinopathy of prematurity and long-term visual impairment associated 
with preterm birth (33)
 Incidence of retinopathy of prematurity by gestational age
 Number requiring treatment
 Long-term visual impairment after retinopathy of prematurity
Intrapartum-related conditions (28)
 Incidence of intrapartum-related neonatal encephalopathy
 Intrapartum-related neonatal encephalopathy case fatality rate
  Mild and moderate/severe long-term impairment following 
intrapartum-related neonatal encephalopathy
Neonatal severe bacterial infections (29)
 Incidence of possible severe bacterial infection
 Neonatal infection case fatality rate by infection syndrome
  Mild and moderate/severe long-term impairment following neonatal 
meningitis and tetanus
Neonatal hyperbilirubinemia (31)
 Incidence of severe neonatal hyperbilirubinemia and kernicterus
 Kernicterus case fatality rate
  Mild and moderate/severe long-term impairment following neonatal 
encephalopathy
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health system capacities, and funding available in different countries 
or even in differing subnational contexts in large countries such as 
India or Nigeria. There is a correlation between these health system 
factors and neonatal mortality rate (3). We therefore grouped coun-
tries into three neonatal mortality rate (NMR) bands as follows: group 
1 (NMR < 5), group 2 (NMR 5 to <15), and group 3 (NMR ≥ 15). 
We used NMR estimates from the UN Interagency Group on Child 
Mortality Estimation (IGME) (1). For South Africa, we used locally 
derived national estimates, with improved methodology to account 
for the effects of HIV on mortality over this time period (20). Table 3 
shows that although almost 90% of neonatal deaths occur in countries 
with NMR ≥ 15, these highest-burden countries have a median of only 
2 physicians per 10,000 population and US$23 spending on capita per 
year, compared with countries with NMR < 5, which have a median 
of 29 physicians per 10,000 population, health spending of US$1452 
per capita, and virtually universal coverage of neonatal intensive care.
We applied this NMR grouping and assigned each study to one of 
these NMR levels based on the national estimate of the NMR in the 
Figure 2. Overview of parameters required and methods for estimation of the global burden of neonatal conditions. aThe analyses for years lived with 
disability and disability-adjusted life years were undertaken in the Global Burden of Disease study for preterm birth and intrapartum-related conditions 
and will be detailed in the articles in the supplement.
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year of the study. We pooled data from all studies in the same mor-
tality group to obtain parameter estimates using meta-analysis and 
applied the resulting parameter estimates to all countries in that mor-
tality group. This approach was used for GBD2010 and the compart-
mental models for all conditions. However, it should be noted that 
the NMRs and the access to and quality of care may vary substan-
tially within individual countries. In countries with large variations 
between different areas, subnational analysis would be preferable but 
this was not possible due to data limitations.
Neonatal Care Coverage
Neonatal outcomes are highly dependent on both gestational age at 
birth and extrinsic influences, particularly the quality of care received. 
During the past few decades, improved availability and quality of neo-
natal care in high-income countries has led to reduced mortality and 
risk of impairment in surviving babies born before 32 wk of gesta-
tion. However, in many settings, quality of care remains low, and this 
may increase the risk of iatrogenic damage, resulting in higher risk of 
impairment in survivors.
Most of the available literature considers outcomes among babies 
who received a particular type of care, in a particular setting, and at 
a particular time. When using these data to estimate outcomes for 
babies born in 2010, results are sensitive to assumptions about the 
likely proportions of babies receiving different levels of care. For 
estimates relating to preterm birth, retinopathy of prematurity, and 
jaundice estimates, we considered the following three scenarios of 
neonatal care:
1. Full availability of all levels of neonatal care (including NICU): 
high-intensity care including as a minimum high-tech moni-
toring, ventilation, and high nurse–to-patient ratio. In many 
settings, this will also include use of surfactant therapy.
2. Some availability of specialized neonatal care (including 
Neonatal Special Care): facility-based care usually in a new-
born ward, with dedicated nursing staff and some availability 
of supportive care, e.g., external heat sources, feeding support 
(cup or nasogastric tube), and antibiotics ± Kangaroo Mother 
Care, in settings with no availability of referral to NICU care. 
These units may have access to some specific low-tech treat-
ments such as oxygen and phototherapy.
3. No availability of specialized neonatal care (basic/limited care 
only): this could be at home or in a facility with no access to 
Neonatal Special Care or NICU care. This category can vary 
from effective simple care at birth with warmth, cleanliness, 
and breastfeeding support, to some settings where the baby is 
delivered onto a dirty floor, not dried or assessed for breath-
ing, and not fed for several hours.
Even in high-income countries, there are very few data on cov-
erage of neonatal care, and data are lacking from other regions. 
table 3. Countries (N =184) according to three levels of neonatal mortality rate showing the variation in context and health system capacity 
around the year 2010 
NMR group 1, 
low mortality, 
NMR < 5
NMR group 2, 
intermediate mortality, 
NMR 5 to <15
NMR group 3, 
high mortality, 
NMR ≥ 15
Birth outcomes Births 13,261,000 41,378,000 80,123,000
Number of countries 46 63 75
Neonatal deaths 42,000 437,000 2,589,000
Stillbirths 47,000 436,000 2,159,000
Total fertility rate (median) 1.7 2.3 4.3
Contextual factors Gross national income per capita (US$, median) 27,215 4,645 1,045
Female literacy rate (% median) 99 91 62
Maternal newborn and 
child care services
Skilled attendant at birth, % (median) 100 98 60
Traditional birth attendant, % (median) 0 9 20
Caesarean delivery, % (median) (median coverage)  24 21 4
Access to NICU care, % of births (median) 100 98 (IQR: 44–99%) 3 (IQR: 2–19%)
Nurse and midwifery personnel per 10,000 
population (median)
57 20 7
Total number of nurses and midwives 8,187,000 6,710,000 3,354,000
% of the global total of nurses and midwives 45% 37% 18%
Physicians per 10,000 population (median) 29 13 2
Total number of physicians 3,266,000 4,344,000 1,513,000
% of global total 36% 48% 16%
Health system funding Government spending on health per capita (US$, median) 1,452 200 23
Out-of-pocket expenditure on health as percentage 
of total expenditure on health (median %)
19 31 41
Official development assistance ($US) (median 
(min/max range))
 To maternal/neonatal per live birth — 5 (0–428) 24 (5–96)
 To child health per child — 2 (0–152) 14 (1–51)
Table adapted from Lawn et al. (3) Data sources: state of the World’s Children 2011 (40), UN Millennium Developmental Goal Report 2011 (41), WhO Global Atlas (42), WhO National health 
Accounts (43), Pitt et al. (44). Note: Country groupings by level of NMR adapted from The Lancet Neonatal series 2005 (45) and estimates exclude nine countries with annual births <10,000.
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For consistency with previous work on coverage of care around the 
time of birth, we estimated coverage of neonatal care based on facility 
birth coverage as included in the Lives Saved Tool. Given the lack of 
data for the coverage of Neonatal Special Care, we assumed this to be 
similar to the coverage of Comprehensive Emergency Obstetric Care, 
which does have national estimates for many countries (21). This is 
likely to overestimate true coverage because much less investment 
has been made in the necessary newborn care competencies although 
neonatal resuscitation has received increased attention in very recent 
years. For NICU coverage, we undertook literature- and Web-based 
searches to identify low- and middle-income countries with data on 
the number of neonatal intensive care beds and further developed 
a coverage indicator based on coverage of facility birth, assuming a 
requirement of approximately one NICU cot per 1,000 live births (see 
Supplementary Information online) (22).
Mortality Estimation
Although the purpose of this supplement is to estimate impairment 
among survivors of neonatal conditions, and not to generate new 
estimates of neonatal mortality, the three-step compartmental model 
used required us to estimate case fatality risks and deaths to estimate 
the number of postneonatal survivors. These estimated numbers of 
deaths, based on case fatality risks estimated from relatively few data 
inputs, are less robust than other cause-of-death estimates using other 
methods (2,10) but are presented to provide a consistency check on 
the three-step modeling process.
Mortality estimates are required for the YLL component of DALYs 
and for consistency checks with numbers of deaths generated by 
the case fatality risk approach in the three-step model. There are 
also two estimates of the numbers of neonatal deaths in 2010; one 
by the United Nations (3.1 million) (1) and the second by the IHME 
(2.9 million) and used in GBD2010 (2,14). There are also two sets 
of estimates for causes of deaths within the neonatal period for the 
year 2010, with time trends, one recently published by the IHME as 
part of GBD2010 (Table 4) (14), and one published earlier, with child 
and neonatal cause of death and time trends, in addition to a WHO-
facilitated country clearance process (10). Both have similar inputs 
as vital registration and Verbal Autopsy data, and although the GBD 
modeling methods (Table 4) are different from the UN estimation 
methods, in the main, the neonatal cause-of-death estimates in terms 
of proportions are similar. We will refer to both sets of estimates.
Calculation of DALYs in GBD2010
GBD2010 calculated DALYs for both 1990 and 2010 as the sum of 
YLLs and YLDs. YLDs were calculated by combining estimates of 
the prevalence of the condition at all ages, generated by a Bayesian 
meta-regression tool, DisMod-MR, with a disability weight assigned 
by GBD2010 (Tables 5 and 6) (16,23). In DisMod-MR, all those with 
moderate to severe outcomes were modeled together. This combines 
a range of health state combinations, each with their own disability 
weight. To avoid combined disability from multiple conditions in one 
person exceeding a disability weight of one, a multiplicative function 
of disability weights (DWs) for health states that occur in the same 
person is assumed: DW combined = 1−(1−DW1) × (1−DW2)… × 
(1−DWn). To estimate the distribution of combinations of different 
health states, we took up the distribution of the impairment outcomes 
and combinations of outcomes from one study each for preterm birth 
complications (24) and intrapartum-related neonatal encephalopathy 
(25). These small studies were the only sources of information on the 
distribution of sequelae and their severity. We propagated these dis-
tributions with uncertainty and the relevant disability weight for each 
health state by undertaking 1,000 draws from these to achieve a com-
bined weight. Mild outcomes were modeled separately assuming that 
50% of those with mild impairment had isolated mild motor problems 
and that 50% had mild motor and mild cognitive impairment. Isolated 
cognitive impairment was not considered in GBD2010 for neonatal 
conditions but will be included in the future continuous GBD updates.
YLLs for neonatal conditions in GBD2010 were from IHME esti-
mates using life tables and the Cause of Death Ensemble model 
(Table 4) (14). One important change in GBD methodology related 
to the neonatal period is the removal of both (i) discounting, which 
had the effects of reducing the “value” of a neonatal death compared 
with the death of an adult and (ii) age weighting, which gave higher 
weight for hypothetical adult years lost and lower weight for YLL in 
children and the older adult (26).
GBD2010-Specific Methods and Differences From the Estimates 
in This Supplement
The main differences between GBD2010 and the estimates in this sup-
plement are summarized in Table 7. For preterm birth– and intrapar-
tum-related conditions, the experts in this supplement provided input 
parameters to DisMod-MR. Since submission to GBD in early 2012, 
the input data for all these conditions have been further updated, and 
table 4. Estimation of YLL in GBD2010 
Data inputs
 In GBD2010, the number of cause-specific neonatal deaths was estimated based on 3,363 vital registration, 225 verbal autopsy, and 25 surveillance data 
sources. Estimated mortality from all neonatal conditions were combined and estimates generated for four specific causes: preterm birth complications, 
intrapartum-related neonatal deaths, sepsis and other infectious conditions of the newborn, and other conditions arising in the neonatal period ensuring 
that these added up to the total mortality for neonatal conditions.
Modeling
 Total deaths attributable to neonatal causes (i.e., not all neonatal deaths) were modeled using CODEm estimating deaths for males and females 
separately (16). CODEm is based on five general principles: identifying all available data, maximizing the comparability and quality of the data set, 
developing a diverse set of plausible models, assessing the predictive validity of each plausible individual model and of ensemble models, and choosing 
the model or ensemble model with the best performance in out-of-sample predictive analysis. Possible models are identified based on statistical 
methods (mixed effects linear models or spatial–temporal Gaussian process regression applied to the log of death rates or the logit of cause fractions) 
and combining these with a range of plausible combinations of covariates. Each model is tested on how well it predicts 30% of the data that are 
deliberately left out of a model, using statistical out-of-sample predictive validity measures. The following covariates were considered: health system 
access (a composite covariate measuring various aspects of health service provision), smoking prevalence among women of reproductive age, indoor air 
pollution, anti-retroviral–adjusted HIV prevalence, malnutrition, skilled attendance at birth, in-facility delivery, education among women of reproductive 
age, the log of the total fertility rate, and the natural log of lagged-distributed income per capita. In total, 910 total models were tested based on various 
combinations of these covariates. Ensemble models (averaging results from the best-performing single models) were created, tested, and compared with 
the best-performing individual models. The ensemble models performed better on out-of-sample predictive performance. Each of the four subcauses 
were modeled again separately, using CODEm, and then these subcause estimates were scaled to the total number of neonatal deaths estimated in the 
first step, taking into account the levels of uncertainty associated with each estimate.
Full details are available in the studies of Foreman et al. (46) and Lozano et al. (14).
GBD2010 mortality estimates are presented as part of DALYs in this article and in the two conditions in this supplement with GBD2010 DALYs detailed (preterm and intrapartum-
related conditions). In the comparisons with the three-step compartmental model mortality outputs, both UN and GBD neonatal mortality estimates are discussed.
CODem, cause of death ensemble model; DALYs, disability-adjusted life years; GBD, Global Burden of Disease; ROP, retinopathy of prematurity; YLD, years lived with disability; YLL, years 
of life lost.
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table 5. Classification of disability applied in GBD2010 related to neonatal conditions in terms of domain affected, severity, and consequences on 
daily living 
Domain
Assessment definition used in this 
supplement
Lay description used in GBD2010 in terms of activities 
of daily living (21)
GBD2010 disability 
weight (21) (95% 
uncertainty range)
Neuro- 
developmental
Mild motor 
impairment
Difficulty in everyday motor 
activities but able to move around 
without help
Has some difficulty in moving around but is able to 
walk without help.
0.012 (0.005–0.022)
Mild motor and 
intellectual 
impairment
Cognitive Z-score −1 to −2 SD for 
test (DQ 70–84) and mild motor 
impairment
Has some difficulty in moving around, and is slow in 
learning at school. The person can walk without help, 
work at simple supervised jobs and live independently 
but often needs help to raise children.
0.054 (0.033–0.084)
Moderate motor 
impairment
Difficulty in holding implements, 
dressing, and sitting upright. Able 
to move around with help
Has some difficulty in moving around and has difficulty 
in lifting and holding objects, dressing, and sitting 
upright but is able to walk without help.
0.076 (0.05–0.109)
Moderate motor 
and intellectual 
impairment
Cognitive Z-score −2 to −3 SD for 
test (DQ 55–69) and moderate 
motor impairment
Has some difficulty in moving around, holding objects, 
dressing, and sitting upright and is slow in learning to 
speak and do simple tasks. The person can walk without 
help but requires a lot of help with daily activities.
0.221(0.141–0.314)
Severe motor 
impairment
Inability to walk and absence of 
functional use of hands
Is unable to move around without help and is not able 
to lift or hold objects, get dressed, or sit upright.
0.378 (0.251–0.518)
Severe motor 
and intellectual 
impairment
Cognitive Z-score ≤ −3 SD for 
test (DQ < 55) and severe motor 
impairment
Cannot move around without help and cannot lift or 
hold objects, get dressed, or sit upright. The person 
also has low intelligence, speaks few words, and needs 
a lot of help with all basic daily activities.
0.425 (0.286–0.587)
Seizures Severe epilepsy (>1 
seizure per month); 
untreated epilepsy 
(>1 seizure per 
month); treated 
epilepsy with recent 
seizures (>1 per year 
and <1 per month); 
treated epilepsy 
without recent 
seizures (<1 per 
year)
More than one nonfebrile 
seizure per month
Has sudden, prolonged seizures once a week, with 
violent muscle contractions and stiffness, loss of 
consciousness, and loss of urine or stool control. 
Between seizures, the person has drowsiness, memory 
loss, difficulty concentrating, and anxiety.
0.657 (0.464–0.827)
— Untreated has sudden seizures twice a month, with 
violent muscle contractions and stiffness, loss of 
consciousness, and loss of urine or stool control. Between 
seizures, the person has anxiety about future episodes.
0.42 (0.279–0.572)
— Has sudden seizures once a month, with violent muscle 
contractions and stiffness and loss of consciousness. 
Between seizures, the person has some drowsiness, 
difficulty concentrating, and anxiety about future episodes.
0.319 (0.211–0.445)
— Had sudden seizures in the past, but they have stopped 
now with medicines. The person has some drowsiness, 
difficulty concentrating, and some anxiety about future 
episodes.
0.072 (0.047–0.106)
Vision Mild visual 
impairment
Visual acuity in the best eye 
<6/12 but better or equal to 6/18, 
or corresponding visual field loss
Has some difficulty with distance vision, for example, 
reading signs, but no other problems with eyesight.
0.004(0.001–0.1)
Moderate visual 
impairment
Visual acuity in the best eye < 6/18 
but better or equal to 6/60, or 
corresponding visual field loss
Has vision problems that make it difficult to recognize 
faces or objects across a room.
0.033(0.02–0.52)
Severe visual 
impairment
Visual acuity in the best eye 
< 6/60 but >3/60, or visual field 
loss
Has severe vision loss, which causes difficulty in daily 
activities, some emotional impact (for example, worry), and 
some difficulty going outside the home without assistance.
0.191 (0.129–0.272)
Blindness Visual acuity in the best eye 
<3/60, or corresponding visual 
field loss
Is completely blind, which causes great difficulty in some 
daily activities, has worry and anxiety and faces great 
difficulty going outside the home without assistance.
0.195 (0.132–0.272)
Hearing Mild hearing 
impairment
Audiometric hearing threshold 
level of 26–30 decibel (dBHL)
Has difficulty following a conversation in a noisy 
environment but no other hearing problems.
0.005 (0.002–0.012)
Moderate hearing 
impairment
Audiometric hearing threshold 
level of 35–64.9 dBHL
Has difficulty hearing a normal voice and great 
difficulty following a conversation in a noisy 
environment.
0.023 (0.013–0.038)
Severe hearing 
impairment or 
deafness
Audiometric hearing threshold 
level of 65 dBHL or greater
Has great difficulty hearing in any situation or in using 
the phone.
0.032 (0.018–0.051)
10 Pediatric ReseARCh     Volume 74  |  Number s1  |  December 2013  Copyright © 2013 International Pediatric Research Foundation, Inc.
Beyond newborn survival: introduction         Articles
in the following articles in this supplement, we describe where the 
main differences are (27,28).
For neonatal infections, GBD2010 used different data inputs and a 
different approach from the compartmental model presented in this 
supplement (29). For neonatal meningitis, incidence from facility-
based studies (including very preterm babies in NICUs) was used 
to estimate population incidence and impairment risks from older 
infants and children applied (30). For neonatal sepsis, the incidence 
was back calculated from the GBD2010 estimated number of deaths 
using a pooled estimate of case fatality rate for neonatal sepsis. Only 
YLDs from the acute illness were included for neonatal sepsis, assum-
ing the duration of the acute illness to be 1 wk. For neonatal hyperbili-
rubinemia (jaundice), it was included in the category “other neonatal 
conditions” and not estimated separately. YLDs for “other neonatal 
conditions,” which includes all other ICD10 codes in Chapter 9 of 
ICD not captured in the main categories of preterm birth, intrapar-
tum-related conditions, and neonatal infections, were estimated by 
taking the ratio YLD/YLL for intrapartum-related conditions and 
preterm births and applying this ratio to the YLL for the “other neo-
natal conditions” category. As detailed above this is not the same as all 
conditions in the neonatal period because some important conditions 
are not present in Chapter 9 of ICD10 on perinatal conditions, such as 
neonatal tetanus, congenital syphilis, and other perinatal sequelae of 
sexually transmitted diseases. In this supplement, neonatal jaundice, 
which was subsumed in the GBD2010 “other neonatal” category, is 
estimated separately (31).
results
GBD2010 estimates a total of 2.5 billion DALYs worldwide in 
2010. The first 28 d of life are important contributors to this bur-
den, with nearly one-tenth (245 (uncertainty range: 224–265) 
million) of all DALYs estimated to arise from events during the 
first 28 d of life (15). The term “neonatal conditions” includes 
only conditions in the newborn included in Chapter 9 of ICD10 
(International Classification of Diseases) (32), including pre-
term birth, neonatal encephalopathy, and neonatal sepsis, which 
account for an estimated 202 million DALYs, 8.1% (uncertainty 
range: 7.3–9.0%) of the worldwide total (Figure 4). Hence this 
grouping in GBD of “neonatal conditions” does not include sev-
eral important specific infections in the neonatal period, such 
as pneumonia, meningitis, tetanus, or congenital syphilis, which 
are grouped under infectious diseases. Congenital conditions 
are also not included, even if the death occurs in the neonatal 
period.
Summary results from GBD2010 for neonatal conditions 
in 2010 are presented in Table 7, along with a summary 
of any methodological differences between the GBD2010 
DisMod-MR input parameters (or process) and the 2010 
three-step compartmental model used in this supplement. 
More details are given in the other articles in this supplement 
(27–29,31,33).
GBD provides an assessment of change in the burden of 291 
conditions over time, and one notable shift is the reduced con-
tribution of deaths to the DALY total and the increased contri-
bution of disability. Two exceptions to this shift are (i) the con-
tinent of Africa, which still has high premature mortality and 
(ii) neonatal conditions. In contrast with many other condi-
tions, deaths (YLLs) are responsible for the majority of DALYs 
attributable to neonatal conditions across all regions. GBD2010 
estimated that in 2010, 2.84 million deaths occurred in the neo-
natal period and that YLLs contribute 96% of preterm, 88% of 
intrapartum-related conditions, and nearly 100% of neonatal 
sepsis DALYs (Table 7). However, this overall picture, domi-
nated by large numbers of deaths in low-income regions, masks 
the fact that in high- and middle-income regions with relatively 
low mortality levels and increased survival of the sickest new-
borns, YLDs associated with long-term impairment contribute 
a higher proportion of the overall DALYs. For example, YLDs 
comprise 17% of DALYs in high-income countries (34).
The results of GBD2010 suggest that the relative contri-
bution of these neonatal conditions to the global burden of 
DALYs has reduced by 26%, from 10.9% of worldwide total 
(274 million DALYs) in 1990 to 8.1% (202 million) in 2010. 
This reduction in the number of these DALYs is largely 
accounted for by the reduction in the number of deaths (YLLs) 
from these conditions. For conditions for which YLDs are cal-
culated, the total YLDs are estimated to have increased during 
the same period (preterm birth complications by 29.7% and 
intrapartum-related conditions by 9%) due to the increase in 
the number of live births. However, there is substantial uncer-
tainty around these trend estimates, and caution should be 
applied when interpreting these results (see Supplementary 
Information online).
table 6. Estimation of years lived with disability (YLD) in Global Burden of Disease 2010 with Bayesian modeling through DisMod-MR
Data inputs
 For a given condition, data are entered regarding the following epidemiological parameters: prevalence, incidence, mortality risk, remission (i.e., cure) 
rate, and where relevant, the duration of the condition. GBD2010 uses the data sets developed by the IHME for births by country and sex from 1990 to 
2010 and forward projections, along with multiple covariate time series.
Modeling
 DisMod-MR is a complex Bayesian meta-regression tool developed for GBD2010 to combine all available epidemiological data for the parameters 
noted above and estimate the prevalence of a given condition by sex and year. Estimates use a generalized negative binomial model for all the 
epidemiological data, with various types of fixed effects for age, study quality characteristics (such as case definition, representativeness of study), 
country characteristics (such as gross domestic product or level of health service access), and random effects for countries, regions, and superregions 
(16). It aims to estimate all sources of uncertainty as much as possible, including sampling and nonsampling errors. In previous iterations of GBD, 
earlier versions of DisMod concentrated on consistency checking between these parameters. Previous DisMod versions required the analyst to make a 
choice of the most appropriate data points by age and sex for each parameter and for each population of interest. In GBD2010, the aim was to minimize 
such choices by analysts. The software needs to run on a large cluster of servers as it is computationally very intensive. A version that can run on local 
computing resources for use by countries wanting to update their GBD results is being developed. Full details in Vos et al. (16).
GBD2010 YLD estimates are presented as part of DALYs in this article and in the two conditions in this supplement with GBD2010 DALYs detailed (preterm and intrapartum-related 
conditions).
DALYs, disability-adjusted life years; GBD, Global Burden of Disease; IhMe, Institute of health Metrics and evaluation.
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discussion
The recent GBD2010 project has highlighted the increasing 
importance over time of the burden of YLDs (15) and the 
rise of noncommunicable diseases and has drawn attention 
to mental health issues and disabilities, such as those from 
musculoskeletal conditions, while in general, infections and 
maternal conditions have reduced in magnitude of burden. 
Neonatal conditions, however, still constitute an important 
portion of the overall GBD in GBD2010, accounting for 8.1% 
of global DALYs in 2010, which is about the same share as 
in 1990. Their importance is primarily in terms of an excess 
of death very early in life and consequently high numbers 
of YLL. However, in high- and middle-income regions with 
improving survival rates, YLDs have increased in importance. 
It should be noted that GBD2010 starts from live births. The 
2.6 million babies who die as stillbirths in the last trimester of 
pregnancy (35), including the 1.2 million who die as intrapar-
tum stillbirths (17), some just minutes before birth, are not 
yet counted within GBD2010 (36), or indeed in other efforts 
to track global health (37).
These estimates underline the fact that even without count-
ing 2.6 million stillbirths, the burden due to unhealthy birth 
outcomes and newborn complications is important in every 
country and every region of the world. Greater focus on reduc-
ing the incidence of these conditions and improving the care 
of those affected to reduce both early mortality and impaired 
survival is required. Improved coverage and quality of neona-
tal care services are required across the continuum from the 
community, through primary- and secondary-level care to 
neonatal intensive care. In addition, greater accountability for 
counting birth outcomes is critical.
The estimates for neonatal deaths by the Institute of Health 
Metrics and Evaluation (IHME) for GBD2010 and the esti-
mates of the United Nations are remarkably similar at the 
global level, with the estimates for the three major causes 
of neonatal deaths (preterm birth, neonatal infections, and 
intrapartum-related conditions) being within the uncer-
tainty range of each other (Table 7). The slightly lower esti-
mate by the IHME for preterm and intrapartum-related con-
ditions may be counterbalanced by the higher proportion 
filed in “neonatal other,” possibly due to variation in appli-
cation of some specific ICD codes for more recently added 
but common diagnoses (e.g., intraventricular hemorrhage), 
which rely on four-digit codes in ICD, and which, without 
the use of four-digit codes, may be filed in the “other” cat-
egory. If neonatal infections are grouped, then the IHME 
estimate is 750,000 and the UN estimate is 718,000. Yet, the 
split for infection syndromes is very different in the two sets 
of estimates and highlights the challenges of clinical assign-
ment of pneumonia compared with assignment of neonatal 
sepsis or meningitis, given overlapping symptoms (29). The 
inputs, and indeed the methods, between these two sets of 
estimates are broadly similar. However, the increased data 
availability for neonatal cause-of-death estimates while 
encouraging highlights the  ongoing, major gaps for data on 
nonfatal outcomes.
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Time Trends
Overall, considering all conditions, GBD2010 highlighted four 
transitions from 1990 to 2010 (15): first, a demographic transi-
tion, with the overall burden shifting from children to adults; 
however, these results still highlight a big burden in terms of 
absolute numbers in neonatal conditions, with large country/
regional variation and a large unfinished agenda in terms of 
high mortality from many neonatal conditions, especially in 
low-income settings. Second, a disease transition, with a shift 
from communicable (which in GBD also includes maternal and 
neonatal disorders) to noncommunicable disease. However, 
in some regions, e.g., sub-Saharan Africa, the former are still 
very important and despite a 26% estimated reduction in the 
number of DALYs from neonatal conditions from 1990 to 
2010, they still account for more than 200 million DALYs in 
2010 (15). Third, a disability transition, with disability now 
accounting for a third of all DALYs globally and in some high-
income countries, it is more important overall than premature 
mortality; however, for neonatal conditions, premature mor-
tality accounts for almost all (95%) DALYs, especially in low-
income settings. Improvement in quality of care is important 
in reducing both deaths and impairment and should be devel-
oped together. Fourth and finally, a risk transition, with a rapid 
change from poverty to lifestyle risk factors, as exemplified by 
the double burden of under- and overnutrition seen in many 
middle-income countries. However, some neonatal condi-
tions occur, or may even increase, with rising socioeconomic 
levels, e.g., preterm birth, which is very high, for example, in the 
United States. The availability of specialized care for neonatal 
conditions at both Special Care and neonatal intensive care unit 
(NICU) levels may lag behind large societal economic improve-
ments or may be provided but without sufficient quality.
Data to inform these morbidity estimates were limited and 
even more limited over time, hence caution should be applied 
when interpreting trend results. GBD2010 estimated time 
trends for all conditions including neonatal ones. Data to input 
into these conditions were challenging and increasingly so for 
older data to inform 1990 estimates. Due to data constraints 
around the reliability and comparability of the available data 
to provide time trends for some conditions, in the compart-
mental model, we only estimated time trend data for intrapar-
tum-related conditions. Moving forward, it will be critical to 
ensure comparability in measurement and reporting to enable 
improved tracking of any real changes in outcome, avoiding 
measurement and case ascertainment artifacts.
Limitations
GBD2010 had a very wide scope and standard approaches across 
conditions were required; hence, the level of granularity that a spe-
cialist reader may desire was not always possible. In cases of data 
unavailability from both the literature and expert groups, some 
assumptions were applied by the estimation team, e.g., by assum-
ing that the ratio YLL:YLD for “other neonatal conditions” was 
equal to the YLL:YLD ratio for preterm and intrapartum-related 
Figure 4. Global Burden of Disease (GBD2010) estimated distribution of the 2.5 billion disability-adjusted life years for 2010 for all age groups.
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conditions or by back calculating the incidence of neonatal sepsis 
from the number of deaths and the uncertain case fatality rate. 
One such area where the standard approach used in GBD2010 
may be more challenging for estimation of neonatal condition 
is the use of the “steady state” assumption. This assumption was 
used in GBD2010 to estimate prevalence of a condition across all 
ages and was applied to the data on incidence, case fatality, and 
impaired survival from 2010, along with the excess mortality to 
the whole population at all ages in 2010. This was done to enable 
the calculation of comorbidity and is a reasonable assumption 
in a condition whose incidence, duration, case fatality rate, and 
impaired survival do not vary substantially over time. However, 
this is not the case for neonatal conditions, e.g., a preterm baby 
born at 29 wk gestation in 1945, if he/she survives, would be in 
the 65- to –69-y age group in 2010. Assuming the same neonatal 
survival for all ages as for a baby born in 2010 will overestimate 
the number of survivors in historical cohorts pre-NICU, even 
in a high-income country. Moreover, given major changes over 
time, GBD steady state assumptions may over- or underestimate 
the risk of impairment in survivors depending on the evolution-
ary stage of NICU. In view of this changing care and outcomes 
over time, in the subsequent articles in this supplement, we focus 
on incident cases in the year 2010.
In addition to the paucity of available data, substantial varia-
tion was found in the quality and comparability of many of the 
studies, especially when considering impairment outcomes over 
time, across settings, and with the absence of a uniform metric 
to assess disability. Many studies report outcomes using different 
assessment tools, applied at different ages, and by pooling dif-
ferent groups of babies at risk, limiting the comparability across 
studies. In addition, many studies report on the number in a 
given risk group with each of the given outcomes, e.g., number 
with cerebral palsy, number with visual impairment, or number 
with cognitive impairment, without giving any information on 
those with more than one impairment to allow estimation of the 
overall number of children with moderate to severe impairment. 
Ideally, all studies would have assessed children at the same age. 
Many studies also publish results of the assessment of the cohort 
at several points, e.g., at 2 y, at 6–8 y, and then in adolescence, in 
most cases, with increasing levels of loss to follow-up over time 
(38). We sought to balance the loss of data due to loss to follow-
up with the ability to be able to predict long-term impairment 
and included only cohorts with minimum follow-up time of 18 
mo; however, this may only be a moderate predictor of long-
term outcomes, especially in preterm survivors (39). Where 
more than one assessment of a cohort was available, we used 
data from the primary school–aged assessment.
The GBD summary results have been published elsewhere 
(15), and an overview of the neonatal-specific methodology and 
results are presented in this article. The subsequent articles in 
this supplement (Table 2) (27–29,31,33) provide further details 
of the specific methodology and data inputs by condition for 
newborns advancing further from the data used in GBD2010, 
while noting some remaining important data limitations. We 
build on the lessons that we learnt out of GBD2010 to further 
refine the assumptions made and have updated the data inputs 
in the subsequent articles that provide estimates of number of 
impaired survivors for each condition for 2010 using a com-
partmental model. We provide a full description of the steps 
taken in terms of input parameters and process for the models. 
Our aim is that by providing the details in terms of numbers of 
incident cases, deaths, and long-term impaired survivors, the 
data will be more effectively used to inform planning of health, 
education, and social services and also be useful for improved 
data collection to better track these outcomes.
These estimates have presented substantial challenges in 
terms of limitations in the current data. The data gaps are not 
uniform across conditions, geography, and time. Substantial 
inequity is shown not only in terms of outcomes of these con-
ditions but also in data to inform these outcomes. For example, 
preterm birth, which is common in high-income countries, 
has much more data globally than for neonatal infections in 
term babies, which are much more common in poor coun-
tries. Improving future estimates will require both improved 
methods of using the available data, for example, refining the 
modeling methods, and also, most crucially, improvements in 
data collection using consistent definitions and tools and from 
a wider range of sources and geographies.
Conclusion
The results of the GBD2010 work and the results of the compart-
mental models described in this supplement highlight the large 
burden that newborn conditions contribute to deaths and ill-
health in populations throughout the world in 2010—even the 
data limitations cannot mask this, although they may particularly 
miss the impairment outcomes. Reducing neonatal mortality is 
still an important unfinished agenda in all settings. Our aim is 
to draw more attention to the growing importance of neonatal 
morbidity, the global burden of long-term impairment associ-
ated with these conditions, and the economic loss to families 
and nations, in addition to outlining the associated measurement 
challenges to improve data collection in the future. We hope 
that this publication will help engage the pediatric, obstetric, 
and public health communities to work together to strengthen 
programs, policies, and data to prevent and manage these condi-
tions, in addition to aiding in development of services for those 
with impairment following neonatal and other insults.
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